HERBALIFE LTD.
For the period ended Mar 31, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 30, 2025
HLF$15.59-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31,2025 | December 31,2024 | |
|---|---|---|
| (in millions, except share and par value amounts) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $329.4 | $415.3 |
| Receivables, net of allowance for doubtful accounts | 90.1 | 68.9 |
| Inventories | 488.0 | 475.4 |
| Prepaid expenses and other current assets | 186.5 | 184.1 |
| Total current assets | 1,094.0 | 1,143.7 |
| Property, plant, and equipment, at cost, net of accumulated depreciation and amortization | 450.3 | 460.2 |
| Operating lease right-of-use assets | 183.6 | 185.7 |
| Marketing-related intangibles and other intangible assets, net | 311.9 | 312.3 |
| Goodwill | 89.2 | 87.7 |
| Deferred income tax assets | 414.3 | 398.6 |
| Other assets | 141.0 | 139.9 |
| Total assets | $2,684.3 | $2,728.1 |
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $85.4 | $70.0 |
| Royalty overrides | 306.4 | 334.1 |
| Current portion of long-term debt | 218.7 | 283.5 |
| Other current liabilities | 518.5 | 542.8 |
| Total current liabilities | 1,129.0 | 1,230.4 |
| Long-term debt, net of current portion | 1,975.0 | 1,976.6 |
| Non-current operating lease liabilities | 167.4 | 169.5 |
| Other non-current liabilities | 148.9 | 152.7 |
| Total liabilities | 3,420.3 | 3,529.2 |
| Commitments and contingencies | ||
| Shareholders’ deficit: | ||
| Common shares, $0.0005 par value; 2.0 billion shares authorized; 101.6 million (2025) and 101.2 million (2024) shares outstanding | 0.1 | 0.1 |
| Paid-in capital in excess of par value | 287.9 | 278.2 |
| Accumulated other comprehensive loss | (266.4) | (271.4) |
| Accumulated deficit | (757.6) | (808.0) |
| Total shareholders’ deficit | (736.0) | (801.1) |
| Total liabilities and shareholders’ deficit | $2,684.3 | $2,728.1 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.